Showing 13,201 - 13,220 results of 31,612 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (nn decrease)) ))', query time: 1.34s Refine Results
  1. 13201

    Data_Sheet_1_Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review.docx by Natalia Sutiman (2635069)

    Published 2020
    “…Increase in volume of distribution attributable to ECMO was demonstrated for nine (56%) drugs: cefotaxime, gentamicin, piperacillin/tazobactam, fluconazole, micafungin, levetiracetam, clonidine, midazolam, and sildenafil (range: 23–345% increase relative to non-ECMO controls), which may suggest the need for higher initial dosing. Decreased volume of distribution was reported for two drugs: acyclovir and ribavirin (50 and 69%, respectively). …”
  2. 13202
  3. 13203
  4. 13204

    Effects of hNGFP61S/R100E on Aβ plaque load revealed by immunohistochemistry, Thioflavin S staining and ELISA. by Simona Capsoni (161132)

    Published 2012
    “…Scale bars in A–F = 1000 µm. Scale bars in G–H = 50 µm.</p>…”
  5. 13205
  6. 13206
  7. 13207
  8. 13208
  9. 13209
  10. 13210

    Image_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.jpg by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
  11. 13211

    Table_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.docx by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
  12. 13212

    Data_Sheet_1_Hypoglossal nerve stimulation in adolescents with down syndrome and obstructive sleep apnea: A systematic review and meta-analysis.docx by Pan Liu (527011)

    Published 2022
    “…A total of 106 patients were included. All the studies showed that patients receiving hypoglossal nerve stimulation experienced a significant decrease in apnea-hypopnea index (at least 50%). …”
  13. 13213

    A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain. by Amit Benbenishty (6524375)

    Published 2019
    “…Scale bar is 500 μm for the images on the left and middle, and 50 μm for the images on the right. (<b>c-f</b>) A single prophylactic systemic (i.p.) injection of 4 mg/kg CpG-C resulted in reduced growth of experimental brain metastases, as indicated by bioluminescence and fluorescence imaging. …”
  14. 13214
  15. 13215
  16. 13216
  17. 13217
  18. 13218
  19. 13219
  20. 13220

    Dynamics of soluble <i>Fgfr2b</i> expression and impact on AER maintenance after a single Dox-IP injection. by Soula Danopoulos (346564)

    Published 2013
    “…(<b>C</b>) Quantification of <i>soluble Fgfr2b</i> by qRT-PCR indicating a peak of expression at 6 hrs and a steep decrease at 24 hrs. …”